scispace - formally typeset
Y

Yan Xing

Researcher at University of Texas MD Anderson Cancer Center

Publications -  89
Citations -  5664

Yan Xing is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Cancer & Breast cancer. The author has an hindex of 39, co-authored 78 publications receiving 4910 citations. Previous affiliations of Yan Xing include Houston Methodist Hospital.

Papers
More filters
Journal ArticleDOI

Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer.

TL;DR: A meta‐analysis of studies that examined the results of SLNB after preoperative chemotherapy found that women with breast cancer are more frequently being treated with preoperative neoadjuvant chemotherapy.
Journal ArticleDOI

Lymphedema beyond breast cancer

TL;DR: A systematic review and meta‐analysis of the oncology‐related literature excluding breast cancer was performed to derive estimates of lymphedema incidence and to identify potential risk factors among various malignancies.
Journal ArticleDOI

Ethnic Differences Among Patients With Cutaneous Melanoma

TL;DR: Understanding melanoma in minority populations may lead to early detection and ultimately save lives, and differences in disease stage at presentation contributes to disparities in survival.
Journal ArticleDOI

Contemporary Diagnostic Imaging Modalities for the Staging and Surveillance of Melanoma Patients: a Meta-analysis

TL;DR: Among the compared modalities, ultrasonography was superior for detecting lymph node metastases, and PET-CT was inferior for the detection of distant metastases in both the staging and surveillance of melanoma patients.
Journal ArticleDOI

Clinicopathology and Outcomes for Mucinous and Signet Ring Colorectal Adenocarcinoma: Analysis from the National Cancer Data Base

TL;DR: Signet ring cell adenocarcinomas of the colon and rectum and mucinous adenOCarcinoma of the rectum are associated with poorer survival and these aggressive histologic variants of colorectal adenoplastoma should be targeted for research initiatives to improve outcomes.